The Neutrino Donut is conducting a technology assessment for a startup in this space.
Category: Technology Marketing
Neutrino Donut Project – Technology Assessment – Lubrication technology – Medical Devices
We completed a technology and market assessment plan for a lubrication technology in the medical device space.
Neutrino Donut Project – Technology Assessment – Vet and First Responder Wellness Application
We developed a technology assessment and market development summary for this technology.
The Neutrino Donut, LLC – Blood Storage Technology
The Neutrino Donut is developing a commercialization summary of a blood storage and recovery technology.
We are providing a summary of the research and commercial opportunities as well as identifying key partners in this space.
The Neutrino Donut, LLC – Luminescent Semiconductors – Business Development Project
The Neutrino Donut, LLC is conducting a business development project on the commercializing a technology in the luminescent semiconductors space. We are connecting with key partners globally seeking licensing opportunities for this technology.
Neutrino Donut Project – Haptic Animation Technology Commercialization
The Neutrino Donut, LLC recently completed a project to evaluate an adaptive animation interface providing haptic feedback. The technology has many potential applications in the gaming and training markets.
Neutrino Donut Project – Patient Reported Outcomes – Commercialization Assessment
The Neutrino Donut completed a commercialization assessment for a technology relating to patient reported outcomes. The use of interviews to evaluate patients is commonplace and part of the development of an overall well being program for the patient. To distinguish one technology opportunity from another, the tech must go through an FDA approval process as well as extensive testing against the historical data from a healthcare organization to ensure hard numbers and cost tracking and savings over a large population and time frame.
In developing the questionnaire, the innovators will look to understand the types of data being collected, the questions which can be asked and answers, and create a link between the two groups.
With the implementation of the Affordable Care Act, the population of patients available for statistical evaluation has greatly increased. Additionally, medical systems and insurance companies focus on cost savings across a population, which would include more effective identification of patients as well as treatment plans which are closely tracked.
Sometimes, it’s not the technology. It’s the data produced by the technology.
Business Development Project – The Neutrino Donut, LLC – Licensing / Distribution Opportunity
The Neutrino Donut, LLC offers the following licensing opportunity in collaboration with EU entity GlobeTech Innovation. All materials presented are public and can be shared with internal and external partners. For more information, please contact Earle Hager, Managing Partner, at ehager81@gmail.com or +1 512 431 3940.
TECHNOLOGY SUMMARY
Loccnel is a novel scientifically proven technology and ready to market product – bioactive peptide based cosmetics, Loccnel Anti Age – Every Day Complex and Loccnel® Anti Age – Every Night Treatment. It has a patent application (Czech patent application PV 2015-707) and has additional paths forward for product development. The process is within the priority period for PCT filings. The products are based upon Alaptide, a novel synthesis and use of bioactive peptide to advance skin regeneration. The products are scientifically proven to provide active cell protection with significant effects on the quality of the skin and strong regenerative effect and are suitable for both women and men. The products have excellent local and systemic tolerability and non-oily texture and have no health burden – excreted in unchanged structure.
DEVELOPMENT STATUS
Specific stability tests were successfully performed, including:
- Physical / Chemical Stability Tests
- Microbiological Quality Testing
- Preservative Challenge Testing
- Stability and Shelf Life Testing
- Non-Animal Safety / Toxicity Testing
- Microbiological Stability Tests
- Packaging Stability Tests
- Custom Testing
- All results are in compliance with legal requirement for cosmetic products.
Preclinical studies demonstrated positive effect on the proliferation of cells, physiological and regenerative processes, such as reducing and removing wrinkles and scars, accelerating epithelization and healing process demonstrably, and stimulating growth of granulation tissue (in healing applications).
Future clinical development plans include:
- Loccnel® 2nd generation production
- Development of nanofiber based carrier with active healing component (plus patent protection)
- Production of a substance optimization (patent protection)
- Analytical assessments – for pharmaceutical-analytical documentation
- Development of new dosage forms (patent protection)
- Preclinical testing of the effectiveness of the SLP
- Study of the mechanism of action – influence on epidermal growth factor
- Metabolic studies
- Pharmacokinetics after topical application, also penetration of a new form
- Toxicology (genotoxicity, irritability, safety pharmacology, side effects)
- Clinical trials – necessary from I to III.
KEY INNOVATORS
These products were developed by Dr. Pavel Martásek, an internationally renowned expert in research of structural functional determinants of the synthesis of gaseous molecules, important agents in normal and pathologic conditions, and in the field of heme synthesis and degradation and Dr. Vladimír Král, a leading researcher in supramolecular chemistry, nanotechnology, and molecular engineering.
NEXT STEPS
The company is seeking a partner for Loccnel® products – sales / distribution and licensing the technology as well as a research and development partner for next generation products. The company is looking for a partner who can provide global leadership in the distribution of the product.
For more information, please contact Earle Hager, Managing Partner, The Neutrino Donut, LLC at ehager81@gmail.com or +1 512 431 3940.
Neutrino Donut Project – Diabetes Technology
The Neutrino Donut just completed a project working with a company on a diabetes related technology. As part of the process, we helped define markets and their relating opportunities, worked with the negotiations with a university tech transfer group, and helped define the company structure. The market discussions centered around a specific v. global opportunity. The negotiations discussions with the tech transfer office had a focus on defining product development from the university perspective v. the commercial markets, anticipated carve outs for other negotiations, and the process of defining the value of the startup v. potential licenses with larger companies from the university’s perspective. The definition of the company structure centered around the long term v. short term/buy out process for the company and where the finish line was located for each strategy. The project was developed in conjunction with a patent law firm, who identified The Neutrino Donut, LLC as an effective consultant for their client.
University technologies, check them out.
Neutrino Donut Project – First Responder – Defense Technology
The Neutrino Donut completed a technology assessment of a device used for first responders. The analysis included a review of the patent and research opportunities as well as next steps forward in product development.